Tipranavir C-14

DB15108InvestigationalSmall molecule

Tipranavir C-14 is under investigation in clinical trial NCT02253797 (Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects).

Chemical structure of Tipranavir C-14
Formula / weight
C31H33F3N2O5S · 604.66 g/mol (avg)
Also known as
14C-TIPRANAVIR

Resolves to

Compound
UNIIVU8T5RB4VWCAS1141509-98-9ChEMBLCHEMBL445699
Structure
InChIKeySUJUHGSWHZTSEU-MWQIXQBFSA-NSMILESCCC[C@@]1(CCC2=CC=CC=C2)CC(O)=C([14C@H](CC)C2=CC=CC(NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)=C2)C(=O)O1

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Tipranavir C-14, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In